Mark Kidd

7PUBLICATIONS
5CO-AUTHORS
Central nervous systemNanotoxicology, health and safetyMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersPacific Peoples computing technology use and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
NETest2.0® Demonstrates Superior Monitoring Performance Compared with Chromogranin A in Neuroendocrine Tumor Surveillance.

|Jun 12, 2026
Analytical Validation of NETest2.0®, a Novel Multigene Blood-Based Molecular Assay for Neuroendocrine Tumors.

|Mar 14, 2026
Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate Cancer.

Kambiz Rahbar, Martin Bögemann, Philipp Papavasilis

|Feb 13, 2025
NETest® 2.0-A decade of innovation in neuroendocrine tumor diagnostics.

M Kidd, I A Drozdov, A Chirindel

|Jan 22, 2025
Clinical Sensitivity and Specificity of the PROSTest in an American Cohort.

Kambiz Rahbar, Mark Kidd, Vikas Prasad

|Apr 04, 2024
Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole blood.

Irvin M Modlin, Mark Kidd, Ignat A Drozdov

Pageof 2

Frequent Collaborators

2 joint publications

Srinivas V Koduru

1 joint publications

J Strosberg

1 joint publications

Jolanta Kunikowska

1 joint publications

Kambiz Rahbar